Table 1 Baseline characteristics of the entire cohort and of the PS-matched cohort
Overall cohort | PS-matched cohort | |||||
|---|---|---|---|---|---|---|
Group A | Group B | Difference Group B – Group A | Group A | Group B | Difference Group B – Group A | |
n | 77 | 40 | 40 | 40 | ||
Males (n) (%) | 26 (33.8 %) | 15 (37.5 %) | -11 (-3.80 %) | 15 (37.5 %) | 15 (37.5 %) | 0 |
Mean Age (years) (±SE) | 51.87 (±1.60) | 50.18 (±2.43) | -1.69 | 49.40 (±2.05) | 50.18 (±2.43) | 0.78 |
Mean FEV1 % predicted (±SE) | 82.23 (±1.14) | 81.93 (±2.00) | -0.30 | 82.40 (±1.63) | 81.93 (±2.00) | -0.47 |
Comorbidities (% of patients) | 37.7 % | 42.5 % | -4.80 % | 42.5 % | 42.5 % | 0 |